The use of psychological supportive care services and psychotropic drugs in patients with early-stage breast cancer: a comparison between two institutions on two continents

Kaidar‐Person, Orit; Meattini, Icro; Deal, Allison M.; Carta, G; Terzo, L.; Camporeale, Jayne; Muss, Hyman B.; Marks, Lawrence B.; Livi, Lorenzo; Mayer, Deborah K.; Zagar, Timothy M.

doi:10.1007/s12032-017-1003-5

Cited by 10 publications

(5 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Besides, in Gonzalez et al's cohort study, the participants practised Islam, and daily prayers affected their sleep duration. Moreover, we found that less than 16% of participants in this study were taking sedative-hypnotic drugs, which is lower than the breast cancer patients in the United States (43.8%) and comparable to Italy (18.2%) (Kaidar-Person et al, 2017). Patients are often reluctant to take sedative-hypnotic drugs due to the side effects of the drug and fear of addiction (Cogan et al, 2022).…”

Section: Williams Et Al 2005)mentioning

confidence: 62%

Factors associated with the sleep disturbances of people with breast cancer during chemotherapy in China: A cross‐sectional study

Zhu

Gao

et al. 2023

Nursing Open

View full text Add to dashboard Cite

Aim:The aim of the study was to investigate the incidence of sleep disturbance and its relationship with anxiety and depression symptoms, social support and hope in breast cancer patients in China during chemotherapy.Design: A single-centre cross-sectional study.Methods: A total of 329 breast cancer patients were selected via convenience sampling method before they began chemotherapy (n = 115), before the 5th week of chemotherapy (n = 117) or 1 month after chemotherapy ended (n = 97) and administered paper-and-pencil questionnaires to evaluate sleep quality, depression and anxiety symptoms, social support and hope. Risk factors significantly associated with sleep disturbance during bivariate were incorporated in the multivariate analysis. Bivariate analyses showed that age, menopausal status, depression and anxiety symptoms, emotional/informational support, tangible support, affectionate support, positive social interaction and total support were predictors of sleep disturbance.Results: Sleep disturbance was prevalent in breast cancer patients before (27.0%), during (32.5%) and after (39.2%) chemotherapy, with 37.4%, 41.9% and 52.6% of participants, respectively, reporting sleeping below the recommended 7 h. Only 8.6%-15.5% of patients reported taking sedative-hypnotic drugs during the chemotherapy.Multivariate analyses found that participants reporting clinically significant anxiety (HADS > 8) were 3.5 times more likely to report sleep disturbance (PSQI > 8) than participants without clinically significant anxiety, and each increment in emotional/ informational support was associated with a 9.04% reduced risk of sleep disturbance.Moreover, age was an independent predictor of sleep disturbance during multivariate modelling.

show abstract

Section: Williams Et Al 2005)mentioning

confidence: 62%

Factors associated with the sleep disturbances of people with breast cancer during chemotherapy in China: A cross‐sectional study

Zhu

Gao

et al. 2023

Nursing Open

View full text Add to dashboard Cite

show abstract

“…It is also known from other studies that cancer survivors desire individual counselling by professionals the most in contrast especially to anti-depressants or other psychiatric medication [ 55 ], but medication is what they receive the most [ 56 ]. It seems that this is a specific problem in the US, where 44% of patients with breast cancer received psychotropic medication, compared to only 18% in Italy [ 21 ].…”

Section: Discussionmentioning

confidence: 99%

“…In our view, nutritionists, for example, are very important to meet nutritional information needs, but they cannot provide psychotherapeutic help (and vice versa). In some studies investigating care provision, the different groups of carers were unfortunately combined quite broadly, which makes it difficult to estimate to what extent care needs are met [ 20 , 21 ].…”

Section: Introductionmentioning

confidence: 99%

Awareness, offer, and use of psychosocial services by breast cancer survivors in Germany: a prospective multi-centre study

Schnittger

Janni

Kühn

et al. 2022

Arch Gynecol Obstet

View full text Add to dashboard Cite

Purpose This study examined the pattern of psychosocial care in breast cancer survivors. Methods In a prospective study with measurements before surgery, 1 month, 8 months, and 5 years thereafter, we examined the proportion of breast cancer survivors who were aware about, had been offered and received various types of psychosocial services from psychologists, social workers, doctors, self-help groups etc. The degree of helpfulness per service among users was ascertained with Likert scales. Determinants of awareness, offer and use were investigated using binary logistic regression analyses. How the services are inter-related was tested with principal component analyses. Results Among 456 breast cancer survivors who participated until 5 years, psychological services were known by 91%, offered to 68%, and used by 55% of patients. Social services were known by 86%, offered to 65%, and used by 51%. Women ≥ 65 years were less likely to be informed about (odds ratio (OR) 0.2) and get offers for psychosocial services (OR 0.4 for social and 0.5 for psychological services) than women < 65 years. The services rated most helpful were social services in the hospital, psychological counselling by a consultant and psychotherapy in private practices. Conclusion These findings underline the importance of psychosocial support by physicians in addition to the "professional" mental health and social care providers. They also show that elderly women in need for support might be in danger of not being well-informed about the services available.

show abstract

“…Moreover, higher levels of inflammation and the long-term effect of antiendocrine therapies were found to be correlated with PTSD in patients with breast cancer (Brown et al, 2020). It should also be mentioned that there is usually a large time gap between PTSD symptoms and the initiation of its treatment (Kadan-Lottick et al, 2005;Kaidar-Person et al, 2017). However, when symptoms of trauma become more pervasive and fail to fade over time, clinical intervention might be necessary.…”

Section: Introductionmentioning

confidence: 99%

EMDR in Cancer Patients: A Systematic Review

Pomeri

Salvia²,

Carletto³

et al. 2021

Front. Psychol.

View full text Add to dashboard Cite

Background: Psychological distress is common among patients with cancer, with severe consequences on their quality of life. Anxiety and depression are the most common clinical presentation of psychological distress in cancer patients, but in some cases cancer may represent a traumatic event resulting in posttraumatic stress disorder (PTSD). Currently, Eye Movement Desensitization and Reprocessing (EMDR) therapy is considered an evidence-based treatment for PTSD, but recent studies also showed its effectiveness for anxiety and depression. The aim of the present systematic review is to summarize the current literature on the effect of EMDR on cancer-related psychological distress.Methods: A literature search was conducted for peer-reviewed articles about “EMDR” and “cancer patients” in the following electronic databases: PubMed, MEDLINE, Science Direct, Google Scholar, and Cochrane library.Results: Our search identified 7 studies in which EMDR was used with a total of 140 cancer patients. The psychiatric diagnosis was PTSD in 3 studies. Otherwise, the diagnosis concerned the anxious and depressive disorder spectrum. Overall, EMDR treatment schedules used were highly heterogeneous, with a different number of sessions (from 2 to 12) and a different duration of therapy (up to 4 months). However, across all studies analyzed EMDR therapy was judged to be adequate in reducing symptoms of psychological distress in this population.Conclusions: According to the results of our analysis, the level of evidence regarding EMDR efficacy in cancer patients is limited by the scarcity of studies and their low methodological quality. Although better quality research is needed, available data suggest that EMDR could be a promising treatment for psychological distress in patients with cancer.

show abstract

The use of psychological supportive care services and psychotropic drugs in patients with early-stage breast cancer: a comparison between two institutions on two continents

Cited by 10 publications

References 26 publications

Factors associated with the sleep disturbances of people with breast cancer during chemotherapy in China: A cross‐sectional study

Factors associated with the sleep disturbances of people with breast cancer during chemotherapy in China: A cross‐sectional study

Awareness, offer, and use of psychosocial services by breast cancer survivors in Germany: a prospective multi-centre study

EMDR in Cancer Patients: A Systematic Review

Contact Info

Product

Resources

About